Waiting lists for HIV drugs swell as US economy weakens

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.607, 2010-01, pp. : 8-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Drug Treatment Outcomes for Persons on Waiting Lists

By Chun JongSerl Guydish Joseph Silber Ellen Gleghorn Alice

The American Journal of Drug and Alcohol Abuse, Vol. 34, Iss. 5, 2008-09 ,pp. : 526-533

Informa Healthcare

Access to resources Recommend Favorite

`Potent mix of forces' behind swell in US healthcare spending

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 379, 2002-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Across England, the NHS has spent about £100 million providing private treatment for patients on waiting lists

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 634, 2011-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Emerging anti-HIV drugs

By De Clercq Erik

Expert Opinion on Emerging Drugs, Vol. 10, Iss. 2, 2005-05 ,pp. : 241-274

Informa Healthcare

Access to resources Recommend Favorite

Immunosuppressive Drugs in HIV Disease

Current Topics in Medicinal Chemistry, Vol. 6, Iss. 16, 2006-08 ,pp. : 1769-1789

Bentham Science Publishers

Access to resources Recommend Favorite